Tumor markers, such as carcinoembryonic antigen (CEA) for colorectal liver metastasis, CA19-9 for cholangiocarcinoma, CA-125 for ovarian cancer, and AFP for hepatocellular carcinoma, are measured to provide additional information. This evidence concerns the gene CEACAM5 and hepatocellular carcinoma.